Clinical and pharmacological group: & nbsp

Regenerants and reparants

Included in the formulation
АТХ:

S.01.X.A   Other drugs for the treatment of eye diseases

Pharmacodynamics:

Glycosaminoglycans are the natural components of the connective tissue of the cornea and stimulate the regenerative processes of the cornea.

Pharmacokinetics:

There is no data on the pharmacokinetics of the drug.

Indications:

As part of complex therapy:

- erosion, non-penetrating wounds of the cornea, conjunctiva and sclera;

- penetrating wounds of the cornea and sclera after surgical treatment;

- burns of the cornea, conjunctiva, sclera (chemical and thermal);

- damage to the cornea as a result of surgical interventions (keratotomy, keratomileus, keratoplasty, cataract extraction);

- dry eye syndrome;

- keratitis, including ulceration of the cornea;

- keratoconjunctivitis;

- epithelial-endothelial dystrophy of the cornea;

- with contact correction of vision to improve the tolerability of contact lenses;

- as a preventive tool for involuntary changes in the cornea.

VII.H00-H06.H04.1   Other diseases of the lacrimal gland

VII.H15-H22.H16   Keratite

VII.H15-H22.H16.2   Keratoconjunctivitis

VII.H15-H22.H18.1   Bullous Keratopathy

VII.H15-H22.H18.5   Hereditary dystrophies of the cornea

VII.H15-H22.H18.8   Other specified diseases of the cornea

XIX.S00-S09.S05   Injury of the eye and orbit

XIX.T20-T32.T26.1   Thermal burn of the cornea and conjunctival sac

XIX.T20-T32.T26.6   Chemical burn of the cornea and conjunctival sac

XIX.T80-T88.T88.8   Other specified complications of surgical and therapeutic interventions, not elsewhere classified

Contraindications:

Hypersensitivity to the components of the drug; children's age till 18 years; pregnancy; the period of breastfeeding (due to the lack of data on efficacy and safety).

Carefully:

No data.

Pregnancy and lactation:

Contraindicated during pregnancy and lactation.

Dosing and Administration:

In case of any damage to the cornea, including the operating ones, - 1-2 drops 4-5 times a day for 7 days;

In keratitis, keratoconjunctivitis, dry eye syndrome - 1-2 drops 4-5 times a day for 1 month;

With contact correction, the first 3 days in adapting to wearing contact lenses - 2 times a day in the morning and in the evening (after removing the lenses) 2 drops in each eye;

With prolonged wearing of contact lenses - 1-2 drops in the morning and evening in each eye during the entire period of wearing;

With involutional changes in the cornea - 1-2 drops in the morning and evening for a month.

Side effects:

Hyperemia of the conjunctiva, allergic reactions.

Overdose:

No data.

Interaction:

Pharmacological interaction with other drugs is not revealed.

Special instructions:

Store in a dark place at a temperature of no higher than 15 ° C. Shelf life - 2 years. After opening the vial the drug can be used during not more than 15 days.

Instructions
Up